Evidence map›Paper›PMID 34129672›Full record

ReviewILAR journal2020

Research Relevant Conditions and Pathology in Nonhuman Primates.

Chandra Saravanan, Thierry Flandre, Carolyn L Hodo, Anne D Lewis, Lars Mecklenburg, Annette Romeike, Oliver C Turner, Hsi-Yu Yen

Open access · bronzeAbstract readReview
In one paragraph

Review in ILAR journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Translational Utility of the Nonhuman Primate Model.Biological psychiatry. Cognitive neuroscience and neuroimaging · 2022
    Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Chandra SaravananNovartis, Novartis Institutes for BioMedical Research, Preclinical Safety, Cambridge, Massachusetts 02139, USA.ORCID 0000-0002-2219-5588
Thierry FlandreNovartis, Novartis Institutes for BioMedical Research, Preclinical Safety, Basel, Switzerland.ORCID 0000-0003-3038-4802
Carolyn L HodoThe University of Texas MD Anderson Cancer Center, Michale E. Keeling Center for Comparative Medicine and Research, Bastrop, Texas, USA.
Anne D LewisOregon National Primate Research Center, Beaverton, Oregon, USA.
Lars MecklenburgCovance Preclinical Services GmbH, Münster 48163, Germany.
Annette RomeikeCovance Preclinical Services GmbH, Münster 48163, Germany.
Oliver C TurnerNovartis, Novartis Institutes for BioMedical Research, Preclinical Safety, East Hanover, New Jersey, USA.ORCID 0000-0003-0512-1170
Hsi-Yu YenCovance Preclinical Services GmbH, Münster 48163, Germany.
Covance (Germany) · DENovartis (United States) · USNovartis (Switzerland) · CHOregon National Primate Research Center · USThe University of Texas MD Anderson Cancer Center · US

Funding

Upgrade of confocal microscopy at the Oregon National Primate Research CenterP51OD011092 · OD · OREGON HEALTH & SCIENCE UNIVERSITY · PI Bonnie J. Nagel · 2012 to 2026
$203.9M
NIH HHS P51 OD011092
6 · The paper itself

Abstract

Biomedical research involving animal models continues to provide important insights into disease pathogenesis and treatment of diseases that impact human health. In particular, nonhuman primates (NHPs) have been used extensively in translational research due to their phylogenetic proximity to humans and similarities to disease pathogenesis and treatment responses as assessed in clinical trials. Microscopic changes in tissues remain a significant endpoint in studies involving these models. Spontaneous, expected (ie, incidental or background) histopathologic changes are commonly encountered and influenced by species, genetic variations, age, and geographical origin of animals, including exposure to infectious or parasitic agents. Often, the background findings confound study-related changes, because numbers of NHPs used in research are limited by animal welfare and other considerations. Moreover, background findings in NHPs can be exacerbated by experimental conditions such as treatment with xenobiotics (eg, infectious morphological changes related to immunosuppressive therapy). This review and summary of research-relevant conditions and pathology in rhesus and cynomolgus macaques, baboons, African green monkeys, common marmosets, tamarins, and squirrel and owl monkeys aims to improve the interpretation and validity of NHP studies.

Indexed as

PrimatesAnimalsChlorocebus aethiopsMacaca fascicularisMacaca mulattaModels, AnimalPapioPhylogenyAotusChlorocebusmacaquemarmosetmonkey diseasesPapiopathologySaimiri

Identifiers

PMID34129672
PMCPMC8918156
OpenAlexW3165887203

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.